VA hospital launches study of CHF Solutions Aquadex FlexFlow device

October 11, 2019 By Sean Whooley Leave a Comment

CHF Solutions (NSDQ:CHFS) said yesterday that a U.S. Veterans Administration hospital in Florida received approval to begin an outpatient study using its Aquadex FlexFlow system for fluid overload in patients with heart failure.

The study, approved by Tampa’s James Haley Veterans’ Hospital & Clinics institutional review board, will be the first of its kind to run exclusively through the VA.

In July 2018, the department awarded a blanket purchase agreement worth up to $6.5 million for CHF Solutions to supply the Aquadex FlexFlow system for a period of up to five years.

Eden Prairie, Minn.-based CHF Solutions’ Aquadex FlexFlow is an ultrafiltration system designed to remove excess fluid in patients suffering from fluid overload. The platform is indicated for temporary (up to eight hours) and extended (more than eight hours in a hospital setting) ultrafiltration of patients with fluid overload who have failed diuretic therapy.

In March, CHF Solutions touted data from a study that indicated that while the costs of ultrafiltration therapy were higher, fluid removal with ultrafiltration resulted in reduced hospital readmissions and cost savings of approximately $3,975, or 15%, when compared to diuretic therapy. The company acquired the Aquadex device in 2016 for $5 million from Baxter (NYSE:BAX).

CHF Solutions said it submitted an application to the FDA requesting 510(k) clearance for the system to include pediatric patients weighing 44.1 lbs (20 kg) or more.

“We are grateful to be working with JAHVH to initiate a study of the benefits of aquapheresis to manage fluid overload in our nations’ veterans suffering from heart failure,” chairman & CEO John Erb said in prepared remarks. “Currently, heart failure patients suffering from fluid overload are re-admitted into the hospital, placing a heavy economic burden to the healthcare system. We look forward to collaborating with the Veterans Administration to offer this treatment in their facilities for heart patients in the out-patient setting and demonstrating the potential savings to the Veterans Health Administration.”

“We are excited about providing great care to our Veterans suffering from fluid overload with the use of ultrafiltration therapy in an outpatient setting,” added JAHVH advanced heart failure program director Ramona Gelzer Bell. “We believe that in addition to improving quality of life, we are reducing the cost of treating patients suffering from fluid overload. The scientific literature is filled with evidence of the clinical and economic benefits offered by ultrafiltration.”

Shares of CHFS were down -1.4% at $1.44 per share in mid-afternoon trading today.

Harting increases cable assembly supplies in response to COVID-19 pandemic
Harting Technology Group appears to be engaging in a fine balancing act: The Minden, Germany–based company says it is taking numerous measures to protect its employees, while also providing customer-specific cable assemblies for respiratory equipment and other medical devices needed to fight COVID-19. Several German manufacturers are currently producing the devices on which patients and… […]
FDA relaxes rules around ECMO devices during pandemic
The FDA has issued new guidance to help expand the availability of devices used in extracorporeal membrane oxygenation (ECMO) therapy to treat COVID-19 patients. Extracorporeal circuits and accessories for long-term respiratory/cardiopulmonary failure, including devices used for ECMO therapy, provide assisted extracorporeal circulation and physiologic gas exchange of a patient’s blood for more than 6 hours.… […]
Cantel Medical ups production of dental masks for COVID-19
Cantel Medical (NYSE:CMD) announced last week that it is increasing production of its surgical earloop dental mask amid the COVID-19 pandemic. The company is increasing manufacturing by its HuFriedyGroup dental division to 24 hours a day, seven days a week at its two New York manufacturing sites. The expectation is that production volume will increase by… […]
Carbon partners with Adidas, Resolution Medical on COVID-19 response
Carbon, the 3D printing company, announced today that it is working with Adidas on face shields for healthcare workers and with Resolution Medical on nasal swabs for COVID-19 testing. Adidas tweeted about its work with longtime collaborator Carbon, saying the athleticwear company is aiding Carbon’s production of face shields, which healthcare providers are using to… […]
German automotive supplier shifts production to face masks to battle COVID-19
Automotive supplier Wrapping Solutions (Rosengarten, Germany) is partnering with Optima Life Science to produce face masks to help fight the coronavirus pandemic. Wrapping Solutions specializes in producing interior fittings for cars — but has transitioned to sewing 24,000 masks per day at 20 workplaces since March 23. Over the long term, the company plans to… […]
Qosina touts single-use bioprocessing components for coronavirus response
With the bioprocess industry mobilizing to support the development of tests, vaccines and treatments for COVID-19, medtech distributor Qosina said that its supply of single-use bioprocessing components can offer significantly reduced time to clinic and market over multi-use systems during situations like the coronavirus pandemic. Ronkokoma, N.Y.-based Qosina said it also provides 3D CAD models… […]
Could these DIY ventilators stop coronavirus from killing people?
Amid the global crisis caused by the coronavirus pandemic, hospitals and healthcare facilities are reporting shortages of vital equipment that not only keeps the patients safe, but the staffers, too. One important device for which demand has ramped up is ventilators for patients who need assistance with their breathing due to the respiratory effects of… […]
How medtech manufacturers are bringing the fight to coronavirus
As the coronavirus pandemic spreads across the world, contract manufacturers and OEMs continue pivoting to meet the needs of front-line healthcare providers. Here are some of the latest examples: Stryker Stryker (NYSE:SYK) recently announced that it has developed a low-cost, limited-release emergency response bed for use in hospital emergency departments, triage and pop-up areas of… […]
DeviceTalks Weekly: Ep.4 — What does Medtronic’s Puritan reveal mean for medtech?
What does Medtronic’s Puritan reveal mean for medtech? Medtronic earned plaudits and praise for sharing the design specifications for its Puritan Bennett 560 (PB560) ventilators. But will the gesture actually lead to more ventilators being manufactured? In this episode of DeviceTalks Weekly, we’ll talk with experts who will tell us what the plans do and… […]
Newest shortage: Respiratory ventilator repair manuals?
The U.S. Public Interest Research Group says that many manufacturers or respiratory ventilators do not provide access to repair documentation, limiting who can repair the equipment. The advocacy group claims this practice discourages third-party medical repair companies or in-house medical engineers from trying to fix things. So USPIRG, which also sponsors a Right to Repair Campaign, says… […]
Webinar: The digital production floor transformation: Extending your digital edge beyond core systems
Tuesday, May 5, 2020 11:30 am Eastern time / 8:30 am Pacific time Digital transformation efforts are accelerating in a variety of manufacturing areas, yet many producers stop short of digitizing their device history records (DHRs) and other shop floor data collection efforts. Despite the investments manufacturers have made in tried-and-true digitization and… […]